MiR-1301-3p Inhibits Epithelial-Mesenchymal Transition via Targeting RhoA in Pancreatic Cancer

Table 1

Association between miR-1301-3p level and the clinicopathological parameters of pancreatic cancer patients in the study cohort.

Clinical parameters	miR-1301-3p		value
	Low (n= 36)	High (n= 36)
Age (years)	61	64	0.327
Gender			0.637
Male	21	18
Female	15	18
Pathological differentiation			<0.001
Moderate and high	18	33
Poor	18	3
Tumor size (cm)	4.0 ± 1.5	3.7 ± 2.1	0.608
Resection			0.018
R0	24	33
R1 and R2	12	3
Numbers of positive lymph node	5.0 ± 4.5	1.5 ± 1.8	<0.001
Vascular invasion			0.634
Negative	19	22
Positive	17	14
TNM stage			0.285
I and IIA	7	12
IIB and IV	29	24
Primary tumor			0.443
T1 and T2	23	27
T3 and T4	13	9
Regional lymph nodes			0.119
N0	7	14
N1 and N2	29	22
Distant metastases			0.107
Negative	30	35
Positive	6	1